Atrial fibrillation and retinal vein or artery occlusion: Looking beyond the eye

British Journal of Ophthalmology

Volumn 98, Issue 9, 2014, Pages 1141-1143

  Plunkett, Oliver ^a   Lip, Peck Lin ^b   Lip, Gregory Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APIXABAN; DABIGATRAN; RIVAROXABAN; WARFARIN;

AGE; CARDIOLOGIST; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CLINICAL PRACTICE; DISABILITY SEVERITY; DISEASE ASSOCIATION; EDITORIAL; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MEDICAL HISTORY; MORBIDITY; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPHTHALMOLOGIST; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; RETINA VEIN OCCLUSION; RISK ASSESSMENT; RISK REDUCTION; SCREENING TEST;

ATRIAL FIBRILLATION; HUMANS; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; RISK FACTORS; STROKE;

EID: 84906939054     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-304646     Document Type: Editorial

References (19)

1. Jaulim A, Ahmed B, Khanam T, et al. Branch retinal vein occlusion: Epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina 2013;33:901-10.
2. Varma DD, Cugati S, Lee AW, et al. A review of central retinal artery occlusion: Clinical presentation and management. Eye (Lond) 2013;27:688-97.
3. Wong TY, Larsen EK, Klein R, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: The atherosclerosis risk in communities & cardiovascular health studies. Ophthalmology 2005;112:540-47. (Pubitemid 41108850)
4. Bertelsen M, Linneberg A, Rosenberg T, et al. Comorbidity in patients with branch retinal vein occlusion: Case-control study. BMJ 2012;345:e7885.
5. Klein R, Klein BE, Jensen SC, et al. Retinal emboli and stroke: The beaver dam eye study. Arch Ophthalmol 1999;117:1063-68. (Pubitemid 29372940)
6. Hankey GJ, Slattery JM, Warlow CP. Prognosis and prognostic factors of retinal infarction-a prospective cohort study. BMJ 1991;302:499-504.
7. Bruno A, Jones WL, Austin JK, et al. Vascular outcome in men with asymptomatic retinal cholesterol emboli: A cohort study. Ann Intern Med 1995;122:249-53.
8. Klein R, Klein BE, Moss SE, et al. Retinal emboli and cardiovascular disease: The beaver dam eye study. Arch Ophthalmol 2003;121:1446-51. (Pubitemid 37243746)
9. Rubinstein K, Jones EB. Retinal vein occlusion: Long-term prospects: 10 years' follow-up of 143 patients. Br J Ophthalmol 1976;60:148-50.
10. Tsaloumas MD, Kirwan J, Vinall H, et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye (Lond) 2000;14:821-27. (Pubitemid 32007785)
11. Cugati S, Wang JJ, Knudtson MD, et al. Retinal vein occlusion and vascular mortality: Pooled data analysis of 2 population-based cohorts. Ophthalmology 2007;114:520-24. (Pubitemid 46282956)
12. Hu CC, Ho JD, Lin HC. Retinal vein occlusion and the risk of acute myocardial infarction: A 3-year follow-up study. Br J Ophthalmol 2009;93:717-20.
13. Ho J-D, Liou S-W, Lin H-C. Retinal vein occlusion and the risk of stroke development: A five-year follow-up study. Am J Ophthalmol 2009;147:283-90.
14. Glotzer TV, Ziegler PD. Silent atrial fibrillation as a stroke risk factor and anticoagulation indication. Can J Cardiol 2013;29:S14-23.
15. Camm AJ, Lip GY, De Caterina R, et al. Guidelines ESCCfP. 2012 focused update of the esc guidelines for the management of atrial fibrillation. Eur Heart J 2012;33:2719-47.
16. Christiansen CB, Lip GY, Lamberts M, et al. Retinal vein and artery occlusions: A risk factor for stroke in atrial fibrillation. J Thromb Haemost 2013;11:1485-92.
17. Gallego P, Roldan V, Marín F, et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost 2013;110:1189-98.
18. De Caterina R, Husted S, Wallentin L, et al. Vitamin k antagonists in heart disease: Current status and perspectives (section iii). Position paper of the esc working group on thrombosis-task force on anticoagulants in heart disease. Thromb Haemost 2013;110:1087-1107.
19. Lip GY. The role of aspirin for stroke prevention in atrial fibrillation. Nat Rev Cardiol 2011;8:602-06.